Kaplan–Meier survival analyses of seven serum tumor markers in colorectal cancer patients undergoing radical surgery with normal preoperative CEA showed that, for NSE and AFP, negative and positive groups displayed no notable disparities (p > 0.050). The gene discussed is ENO2; the disease is neoplasm.